✦ LIBER ✦

Adherence to disease-modifying antirheumatic drugs and the effects of exposure misclassification on the risk of hospital admission

✍ Scribed by Carlos G. Grijalva; Lisa Kaltenbach; Patrick G. Arbogast; Edward F. Mitchel Jr.; Marie R. Griffin

Publisher: Wiley (John Wiley & Sons)
Year: 2010
Tongue: English
Weight: 76 KB
Volume: 62
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.20087

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effects of disease-modifying antirheumat

Effects of disease-modifying antirheumatic drug treatment on the expression of RANKL and osteoprotegerin in synovial tissue: Comment on the article by Haynes et al

✍ Catrina, Anca Irinel ;Klareskog, Lars 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

Inclusion of glucocorticoids in recommen

Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al

✍ van Tuyl, L. H. D. ;Lems, W. F. ;Voskuyl, A. E. ;Dijkmans, B. A. C. ;Boers, M. ; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 45 KB 👁 2 views

Five-year followup of rheumatoid arthrit

Five-year followup of rheumatoid arthritis patients after early treatment with disease-modifying antirheumatic drugs versus treatment according to the pyramid approach in the first year

✍ Suzan M. M. Verstappen; Johannes W. G. Jacobs; Johannes W. J. Bijlsma; Anton H. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

## Abstract ## Objective To evaluate whether the clinical advantages observed after 1 year in a randomized controlled clinical trial, in which 2 treatment strategies were compared (the early disease‐modifying antirheumatic drug [DMARD] approach versus the pyramid approach), persist after 5 years.

Impact of synthetic and biologic disease

Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: A prospective, open-label, parallel-cohort, single-center study

✍ Cem Gabay; Michael Bel; Christophe Combescure; Camillo Ribi; Sara Meier; Klara P 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

The good initial response to therapy wit

The good initial response to therapy with a combination of traditional disease-modifying antirheumatic drugs is sustained over time: The eleven-year results of the Finnish rheumatoid arthritis combination therapy trial

✍ Vappu Rantalaiho; Markku Korpela; Pekka Hannonen; Hannu Kautiainen; Salme Järven 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Does treatment with glucocorticoids or w

Does treatment with glucocorticoids or with disease-modifying antirheumatic drugs reduce the rate of radiographic progression in rheumatoid arthritis? Comment on the article by Abu-Shakra et al

✍ John R. Kirwan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views